Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 182

1.

Cardiac Toxicities in the Era of Precision Medicine: Underlying Risk Factors, Targeted Therapies, and Cardiac Biomarkers.

Blaes AH, Thavendiranathan P, Moslehi J.

Am Soc Clin Oncol Educ Book. 2018 May 23;(38):764-774. doi: 10.1200/EDBK_208509. Review.

2.

Cardiovascular pharmacology of K2P17.1 (TASK-4, TALK-2) two-pore-domain K+ channels.

Staudacher I, Illg C, Chai S, Deschenes I, Seehausen S, Gramlich D, Müller ME, Wieder T, Rahm AK, Mayer C, Schweizer PA, Katus HA, Thomas D.

Naunyn Schmiedebergs Arch Pharmacol. 2018 Jul 14. doi: 10.1007/s00210-018-1535-z. [Epub ahead of print]

PMID:
30008082
3.

[Novel mechanisms in the initiation and maintenance of atrial fibrillation: tailored individual treatment].

Kugler S, Duray G, Préda I.

Orv Hetil. 2018 Jul;159(28):1135-1145. doi: 10.1556/650.2018.31087. Review. Hungarian.

PMID:
29983108
4.

Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and Prevention.

Armenian SH, Armstrong GT, Aune G, Chow EJ, Ehrhardt MJ, Ky B, Moslehi J, Mulrooney DA, Nathan PC, Ryan TD, van der Pal HJ, van Dalen EC, Kremer LCM.

J Clin Oncol. 2018 Jul 20;36(21):2135-2144. doi: 10.1200/JCO.2017.76.3920. Epub 2018 Jun 6.

PMID:
29874141
5.

Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy.

Han X, Zhou Y, Liu W.

NPJ Precis Oncol. 2017 Sep 12;1(1):31. doi: 10.1038/s41698-017-0034-x. eCollection 2017. Review.

6.

Plasma homocysteine concentrations in healthy horses and horses with atrial fibrillation.

Mitchell KJ, De Clercq D, Stirn M, van Loon G, Schwarzwald CC.

J Vet Cardiol. 2018 Aug;20(4):276-284. doi: 10.1016/j.jvc.2018.04.007. Epub 2018 May 31.

PMID:
29861401
7.

Estimated prevalence of undiagnosed atrial fibrillation in the United States.

Turakhia MP, Shafrin J, Bognar K, Trocio J, Abdulsattar Y, Wiederkehr D, Goldman DP.

PLoS One. 2018 Apr 12;13(4):e0195088. doi: 10.1371/journal.pone.0195088. eCollection 2018.

8.

Personalized Imaging and Modeling Strategies for Arrhythmia Prevention and Therapy.

Trayanova NA, Boyle PM, Nikolov PP.

Curr Opin Biomed Eng. 2018 Mar;5:21-28. doi: 10.1016/j.cobme.2017.11.007.

PMID:
29546250
9.

AF stroke risk stratification-can we do better?

Lambiase PD.

Int J Cardiol. 2018 Apr 15;257:108-109. doi: 10.1016/j.ijcard.2018.01.020. No abstract available.

PMID:
29506675
10.

Cardiac Channelopathies: Recognition, Treatment, Management.

Hickey KT, Elzomor A.

AACN Adv Crit Care. 2018 Spring;29(1):43-57. doi: 10.4037/aacnacc2018664.

PMID:
29496713
11.

Influence of genetic and non-genetic factors on acenocoumarol maintenance dose requirement in a Tunisian population.

Ajmi M, Omezzine A, Achour S, Amor D, Hamdouni H, Ismaïl FBF, Rejeb NB, Kechrid CL, Boughzela E, Bouslama A.

Eur J Clin Pharmacol. 2018 Jun;74(6):711-722. doi: 10.1007/s00228-018-2423-7. Epub 2018 Feb 26.

PMID:
29479633
12.

Technology Advances to Improve Response to Cardiac Resynchronization Therapy: What Clinicians Should Know.

Auricchio A, Heggermont WA.

Rev Esp Cardiol (Engl Ed). 2018 Jun;71(6):477-484. doi: 10.1016/j.rec.2018.01.006. Epub 2018 Feb 14. Review. English, Spanish.

PMID:
29454549
13.

Recent treatment modalities for cardiovascular diseases with a focus on stem cells, aptamers, exosomes and nanomedicine.

Mittal R, Jhaveri VM, McMurry HS, Kay SS, Sutherland KJ, Nicole L, Mittal J, Jayant RD.

Artif Cells Nanomed Biotechnol. 2018 Feb 15:1-10. doi: 10.1080/21691401.2018.1436555. [Epub ahead of print]

PMID:
29447002
14.

Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial.

Zambon CF, Pengo V, Moz S, Bozzato D, Fogar P, Padoan A, Plebani M, Groppa F, De Rosa G, Padrini R.

Eur J Clin Pharmacol. 2018 May;74(5):571-582. doi: 10.1007/s00228-018-2422-8. Epub 2018 Feb 2.

PMID:
29396738
15.

Personalized Anticoagulation: Optimizing Warfarin Management Using Genetics and Simulated Clinical Trials.

Ravvaz K, Weissert JA, Ruff CT, Chi CL, Tonellato PJ.

Circ Cardiovasc Genet. 2017 Dec;10(6). pii: e001804. doi: 10.1161/CIRCGENETICS.117.001804.

16.

CT based 3D printing is superior to transesophageal echocardiography for pre-procedure planning in left atrial appendage device closure.

Obasare E, Mainigi SK, Morris DL, Slipczuk L, Goykhman I, Friend E, Ziccardi MR, Pressman GS.

Int J Cardiovasc Imaging. 2018 May;34(5):821-831. doi: 10.1007/s10554-017-1289-6. Epub 2017 Dec 8.

PMID:
29222738
17.

Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2.

Chang HM, Okwuosa TM, Scarabelli T, Moudgil R, Yeh ETH.

J Am Coll Cardiol. 2017 Nov 14;70(20):2552-2565. doi: 10.1016/j.jacc.2017.09.1095. Review.

18.

Real-Time Ventricular Fibrillation Amplitude-Spectral Area Analysis to Guide Timing of Shock Delivery Improves Defibrillation Efficacy During Cardiopulmonary Resuscitation in Swine.

Aiello S, Perez M, Cogan C, Baetiong A, Miller SA, Radhakrishnan J, Kaufman CL, Gazmuri RJ.

J Am Heart Assoc. 2017 Nov 4;6(11). pii: e006749. doi: 10.1161/JAHA.117.006749.

19.

Effects of Exercise on Arrhythmia (and Viceversa): Lesson from the Greek Mythology.

Lambiase C, Macerola S, Bosco G, Messina E, Franciosa P.

Adv Exp Med Biol. 2017;1000:85-93. doi: 10.1007/978-981-10-4304-8_6.

PMID:
29098617
20.

Dysfunction of Myosin Light-Chain 4 (MYL4) Leads to Heritable Atrial Cardiomyopathy With Electrical, Contractile, and Structural Components: Evidence From Genetically-Engineered Rats.

Peng W, Li M, Li H, Tang K, Zhuang J, Zhang J, Xiao J, Jiang H, Li D, Yu Y, Sham PC, Nattel S, Xu Y.

J Am Heart Assoc. 2017 Oct 28;6(11). pii: e007030. doi: 10.1161/JAHA.117.007030.

Supplemental Content

Loading ...
Support Center